South Dakota State University Patent applications |
Patent application number | Title | Published |
20160046907 | IN VITRO SYSTEM FOR GENERATION OF ANTIGEN-SPECIFIC IMMUNE RESPONSES - The present invention describes methods to produce vaccines and antibodies, which methods including contacting follicular dendritic cells (FDC) with naïve B-cells to mimic conditions in the germinal center (CG) in vitro, including methods of enhancing antibody production in hybridoma cells and compositions comprising product of the instant methods. | 02-18-2016 |
20150307360 | NOVEL SOLUTION FOR ELECTROPHORETIC DEPOSITION OF NANOPARTICLES INTO THIN FILMS - The present invention describes a non-aqueous organic solution for Electrophoretic Deposition (EPD) of nanoparticles onto thin films, including method of using said non-aqueous organic solution and EPD to produce films containing such nanoparticles for use in LED devices, Li ion batteries, as solar absorbers, and as thin film transistors. | 10-29-2015 |
20150276737 | Immunogenic compositions including SIRS virus - Immunogenic compositions that include swine infertility and respiratory virus (“SRRS virus”) are provided herein. Also provided are kits for producing and using the immunogenic compositions. Vaccines and sera for treatment of SRRS, a method for producing the vaccine, methods for diagnosis of SRRS, and antibodies to the viral agent useful in diagnosis and treatment of SRRS are also provided. Swine infertility and respiratory virus is also referred to herein as Mystery Swine Disease (“MSD”). | 10-01-2015 |
20150150822 | NOVEL CORE-SHELL NANOPARTICLES FOR ORAL DRUG DELIVERY - The invention relates to an oral nanoparticle drug delivery system, including methods for preparing such a system using a hydrophobic water insoluble protein, which nanoparticles may include prolamine to generate said oral drug delivery system. | 06-04-2015 |
20140370110 | POLYMER CONJUGATED PROTEIN MICELLES - The invention encompasses micelle assemblies, compositions having micelle assemblies, and methods for preparing micelle assemblies and compositions thereof. The invention also encompasses a prolamine protein conjugated to a polymer, such as a polyethylene glycol (PEG) chain, which conjugates can be used to prepare micelle assemblies. The invention further encompasses methods of encapsulating molecules using the conjugates of the invention. The micelle assemblies can be used for a variety of applications, such as treating cancer, targeting tumors, reducing the toxicity of a drug in vivo, increasing the efficacy of an encapsulated agent in vivo, protecting an encapsulated agent against degradation, and enhancing the water solubility of a drug or other agent. | 12-18-2014 |
20140313574 | NANOPARTICLE FILMS FOR USE AS SOLAR CELL BACK REFLECTORS AND OTHER APPLICATIONS - Disclosed are methods for forming nanoparticle films using electrophoretic deposition. The methods comprise exposing a substrate to a solution, the solution comprising substantially dispersed nanoparticles, an organic solvent, and a polymer characterized by a backbone comprising Si—O groups. The methods further comprise applying an electric field to the solution, whereby a nanoparticle film is deposited on the substrate. Suitable polymers include polysiloxanes, polysilsesquioxanes and polysilicates. Coated glass windows and methods of forming the coated glass windows using the solutions are also disclosed. The methods may be adapted to form nanoparticle films suitable for use as back reflectors in solar cells, where such nanoparticle-based back reflectors exhibit high reflection and light scattering properties, including use of such back reflectors to fabricate solar cells and other photovoltaic-based and light dependent devices such as television screens, computer monitors, portable systems such as mobile phones, handheld games consoles and PDAs. | 10-23-2014 |
20140308351 | Method of Forming Non-Immunogenic Hydrophobic Protein Nanoparticles, and Uses Therefor - Methods are described for producing non-immunogenic nanoparticles from protein sources by controlling the pH in a nanoprecipitation process. The nanoparticles that are produced by the disclosed methods range in diameter size from about 100 ran to about 400 nm, with a preferred diameter size of from approximately 100 nm to approximately 300 nm, thereby rendering them non-immunogenic. The invention further discloses methods for producing nanoconjugates that are suitable for a variety of therapeutic, diagnostic and other uses. | 10-16-2014 |
20140162873 | MATERIALS AND METHODS FOR PRODUCTION OF ACTIVATED CARBONS - The invention is directed to improved methods for producing high-quality activated carbons from biochar. The invention also provides materials and methods for creation of activated carbons useful for purification of water, adsorption of gases or vapors, and catalyst supports. The methods include ash modification, physical activation, the addition of a catalyst, chemical activation, and removal and/or recycling of the catalyst. The usefulness of the present method is that it results in the production of a high-quality activated carbon from a waste product of the biofuel manufacturing process, thereby increasing the economic sustainability and viability of the biofuel production process itself. | 06-12-2014 |
20140073822 | Rotating Fluidized Bed Catalytic Pyrolysis Reactor - Reactors for the pyrolysis of pyrolyzable matter, pyrolysis systems incorporating the reactors and methods of using the reactors are provided. Also provided are systems and methods for integrating the pyrolysis and hydrodeoxygenation of pyrolyzable matter. The pyrolysis reactors create a horizontally rotating, fluidized-bed to which pyrolyzable matter, such as biomass, may be converted via pyrolysis into liquid fuels and/or value-added chemicals. | 03-13-2014 |
20130210654 | Multiplex Immune Effector Molecule Assay - Methods for detecting at least seven cytokines in a porcine biological sample are provided. Also provided are multiplex assay kits that allow for the detection and quantification of the cytokines in a single reaction mixture. Use of the methods and kits for diagnosis, prognosis, and monitoring of immunity is also contemplated. | 08-15-2013 |
20130202737 | Methods and Composition for EPS-Fortified Ingredients in Cheese - The present disclosure relates to methods and compositions for preparing cheese products with exopolysaccharide (EPS). In particular, an EPS-producing culture is deactivated either before or shortly after combination of the EPS-fortified ingredient with a base milk ingredient, i.e. cheese milk. In many cases, the base milk ingredient is a low or reduced fat ingredient. The base milk ingredient may have an added fat. Also contemplated are cheese products made using the disclosed methods and compositions. | 08-08-2013 |
20120276637 | GENETICALLY ENGINEERED CYANOBACTERIA - The disclosed embodiments provide cyanobacteria spp. that have been genetically engineered to have increased production of carbon-based products of interest. These genetically engineered hosts efficiently convert carbon dioxide and light into carbon-based products of interest such as long chained hydrocarbons. Several constructs containing polynucleotides encoding enzymes active in the metabolic pathways of cyanobacteria are disclosed. In many instances, the cyanobacteria strains have been further genetically modified to optimize production of the carbon-based products of interest. The optimization includes both up-regulation and down-regulation of particular genes. | 11-01-2012 |
20120269842 | ENTEROTOXIGENIC E. COLI FUSION PROTEIN VACCINES - The disclosure relates to fusions of enterotoxigenic | 10-25-2012 |
20120040335 | Identification of Porcine Reproductive and Respiratory Syndrome Virus - An enzyme-linked immunosorbent assay (ELISA) is based on the non-structural protein 7 (nsp7) of porcine reproductive and respiratory syndrome virus (PRRSV) and provides for the simultaneous detection and differentiation of serum antibodies directed against Type 1 (European) and Type 2 (North American) PRRSV. The invention provides a serological assay for the detection and/or differentiation of serum antibodies directed against Type 1 and/or Type 2 PRRSV utilizing PRRSV nsp7 as an antigen, and provides a diagnostic method for the detection of PRRSV infection, epidemiological surveys, and outbreak investigations. The invention may be used either alone or as a follow-up assay to determine the true status of unexpected positive results that may occur using other assays, such as the IDEXX HERDCHEK PRRS ELISA. | 02-16-2012 |
20110318379 | Vaccine for Porcine Post-Weaning Diarrhea Caused by Enterotoxigenic Escherichia Coli - Vaccines and methods for making and using the same. An example vaccine may be a vaccine against enterotoxigenic | 12-29-2011 |
20100136047 | RECOMBINANT NORTH AMERICAN TYPE 1 PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS AND METHODS OF USE - Porcine reproductive and respiratory syndrome virus (PRRSV) is a major problem in the pork industry worldwide. The inclusion of markers in vaccines will allow for diagnostic differentiation of vaccinated animals from those naturally infected with wild-type virus. Using a cDNA infectious clone of North American Type 1 PRRSV, a recombinant green fluorescent protein (GFP) tagged PRRSV has been made, containing deletion of an immunogenic epitope, ES4, in the nsp2 region. GFP and ES4 epitope-based ELISAs compliment the marker identification. | 06-03-2010 |
20100008949 | VACCINE FOR PORCINE POST-WEANING DIARRHEA CAUSED BY ENTEROTOXIGENIC ESCHERICHIA COLI - Vaccines and methods for making and using the same. An example vaccine may be a vaccine against enterotoxigenic | 01-14-2010 |